Electronic devices lose energy as heat due to the movement of electrons. Now, a breakthrough in nanoengineering has produced a new kind of switch that matches the performance of the best traditional designs while pushing beyond the power-consumption limits of modern electronics.
Researchers from the University of Michigan have achieved what scientists have been trying to execute for a long time: designing electronics that harness excitons—pairs of an electron and a corresponding hole (a missing electron) bound together forming a charge-neutral particle—instead of electrons.
The newly designed nanoengineered optoexcitonics (NEO) device featured a tungsten diselenide (WSe2) monolayer on a tapered silicon dioxide (SiO2) nanoridge. The switch achieved a 66% reduction in losses compared to traditional switches while surpassing an on–off ratio of 19 dB at room temperature, a performance that rivals the best electronic switches available on the market.
The health of patients—physical and financial, —depends on how swiftly and efficiently the industry responds to the danger of increasingly sophisticated cyber threats
MBA, PhD, is the Chief Executive Officer of The Parker Institute for Cancer Immunotherapy (PICI — https://www.parkerici.org/), a 501c3 nonprofit organization driving the next generation of cancer treatment by accelerating the development of breakthrough immune therapies to turn all cancers into curable diseases.
Dr. Knudsen most recently served as the Chief Executive Officer of the American Cancer Society (ACS) and ACS Cancer Action Network (ACS CAN), where she led both organizations through a period of transformative growth, significantly expanding research investments, advocacy reach, and direct patient support initiatives. Under her leadership, ACS evolved into a unified, high-performing enterprise, increasing revenue by more than 30 percent and broadening its impact to serve over 55 million lives annually. Moreover, Dr. Knudsen developed and scaled innovative programs that included joint ventures and an impact innovation arm to accelerate progress against cancer.
Prior to ACS, Dr. Knudsen served as Executive Vice President of Oncology Services at Jefferson Health and Enterprise Director of the Sidney Kimmel Comprehensive Cancer Center, growing a multi-state oncology network and spearheading advancements in translational cancer research that increased early access to the most advanced cancer care.
A globally recognized expert in prostate cancer, Dr. Knudsen has authored over 200 scientific publications and generated practice-changing discoveries.
Dr. Knudsen held leadership roles with organizations including the National Cancer Institute Board of Scientific Advisors, the Association of American Cancer Institutes, and the American Association for Cancer Research. She currently serves on the boards of Exai Bio, Paradigm Health, and Research!America, and advises multiple biotech ventures including ArteraAI and Transcarent.
Dr. Knudsen holds numerous awards for her scientific and healthcare accomplishments, and this year will be honored with the Allen Lichter Visionary Leader Award from the American Society of Clinical Oncology (ASCO), recognizing her lifetime achievement of outstanding contributions to the field of oncology.
New research shows that slow oscillations in the brain, which occur during deep sleep and anesthesia, are guided by neuronal excitability rather than structural anatomy.
A new clinical trial suggests stem cell therapy may restore vision in people with advanced dry age-related macular degeneration, a disease that currently has no cure.
The smaller electronic components become, the more complex their manufacture becomes. This has been a major problem for the chip industry for years. At TU Wien, researchers have now succeeded for the first time in manufacturing a silicon-germanium (SiGe) transistor using an alternative approach that will not only enable smaller dimensions in the future, but will also be faster, require less energy and function at extremely low temperatures, which is important for quantum chips.
The key trick lies in the oxide layer that insulates the semiconductor: it is doped and produces a long-range effect that extends into the semiconductor. The technology was developed by TU Wien (Vienna), JKU Linz and Bergakademie Freiberg. The results have now been published in the journal IEEE Electron Device Letters and selected as Editor’s Pick on the cover of the August issue.
OpenAI and NVIDIA today announced a letter of intent for a landmark strategic partnership to deploy at least 10 gigawatts of NVIDIA systems for OpenAI’s next-generation AI infrastructure to train and run its next generation of models on the path to deploying superintelligence. To support this deployment including data center and power capacity, NVIDIA intends to invest up to $100 billion in OpenAI as the new NVIDIA systems are deployed. The first phase is targeted to come online in the second half of 2026 using the NVIDIA Vera Rubin platform.
“NVIDIA and OpenAI have pushed each other for a decade, from the first DGX supercomputer to the breakthrough of ChatGPT,” said Jensen Huang, founder and CEO of NVIDIA. “This investment and infrastructure partnership mark the next leap forward — deploying 10 gigawatts to power the next era of intelligence.”
“Everything starts with compute,” said Sam Altman, cofounder and CEO of OpenAI. “Compute infrastructure will be the basis for the economy of the future, and we will utilize what we’re building with NVIDIA to both create new AI breakthroughs and empower people and businesses with them at scale.”
Every time a eukaryotic cell divides, it faces a monumental challenge: It must carefully duplicate and divide its genetic material (chromosomes) equally, and then rebuild the nuclear envelope around the separated halves. If this process goes wrong, the resulting nuclei can be misshapen or disorganized—features often seen in cancer and aging-related diseases.
A new study from researchers at the Indian Institute of Science (IISc) and Université Paris-Saclay reveals how a key enzyme called Aurora A helps cells pull off this feat. The findings are published in The EMBO Journal.
In dividing cells, structures called spindle poles (or centrosomes) grow in size to generate the microtubule ‘tracks’ that pull chromosomes apart. Once this job is done, the spindle poles must shrink and disassemble so that the nuclear envelope can reform around the separated chromosomes.
Review of “If Anyone Builds It, Everyone Dies: Why Superhuman AI Would Kill Us All” (2025), by Eliezer Yudkowsky and Nate Soares, with very critical commentary.
Yudkowsky and Soares present a stark warning about the dangers of developing artificial superintelligence (ASI), defined as artificial intelligence (AI) that vastly exceeds human intelligence. The authors argue that creating such AI using current techniques would almost certainly lead to human extinction and emphasize that ASI poses an existential threat to humanity. They argue that the race to build smarter-than-human AI is not an arms race but a “suicide race,” driven by competition and optimism that ignores fundamental risks.
